Curis, Inc. (CRIS)
NASDAQ: CRIS · Real-Time Price · USD
0.582
+0.001 (0.09%)
At close: Apr 28, 2026, 4:00 PM EDT
0.584
+0.002 (0.38%)
After-hours: Apr 28, 2026, 5:41 PM EDT
Curis Market Cap
Curis has a market cap or net worth of $23.27 million as of April 28, 2026. Its market cap has increased by 135.07% in one year.
Market Cap
23.27M
Enterprise Value
19.81M
1-Year Change
135.07%
Ranking
Category
Stock Price
$0.58
Market Cap Chart
Since August 1, 2000, Curis's market cap has decreased from $613.20M to $23.27M, a decrease of -96.20%. That is a compound annual growth rate of -11.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 23.30M | 82.03% |
| Dec 31, 2025 | 12.80M | -50.58% |
| Dec 31, 2024 | 25.90M | -65.47% |
| Dec 29, 2023 | 75.00M | 41.51% |
| Dec 30, 2022 | 53.00M | -87.85% |
| Dec 31, 2021 | 436.10M | -9.47% |
| Dec 31, 2020 | 481.70M | 754.08% |
| Dec 31, 2019 | 56.40M | 147.37% |
| Dec 31, 2018 | 22.80M | -80.14% |
| Dec 29, 2017 | 114.80M | -73.48% |
| Dec 30, 2016 | 432.90M | 15.87% |
| Dec 31, 2015 | 373.60M | 189.61% |
| Dec 31, 2014 | 129.00M | -46.69% |
| Dec 31, 2013 | 242.00M | -11.78% |
| Dec 31, 2012 | 274.30M | -23.47% |
| Dec 30, 2011 | 358.40M | 139.25% |
| Dec 31, 2010 | 149.80M | -30.74% |
| Dec 31, 2009 | 216.30M | 354.41% |
| Dec 31, 2008 | 47.60M | -23.10% |
| Dec 31, 2007 | 61.90M | -0.16% |
| Dec 29, 2006 | 62.00M | -64.71% |
| Dec 30, 2005 | 175.70M | -28.84% |
| Dec 31, 2004 | 246.90M | 36.11% |
| Dec 31, 2003 | 181.40M | 438.28% |
| Dec 31, 2002 | 33.70M | -81.39% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Barinthus Biotherapeutics | 25.73M |
| Tempest Therapeutics | 24.67M |
| Marker Therapeutics | 24.18M |
| OSR Holdings | 23.98M |
| Lexaria Bioscience | 23.56M |
| Exicure | 22.69M |
| Vistagen Therapeutics | 22.64M |
| Serina Therapeutics | 22.17M |